Anxiolytic effect of cannabidiol in subjects with social anxiety disorder (2010)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; MARTINIS, BRUNO SPINOSA DE - FFCLRP ; QUEIROZ, REGINA HELENA COSTA - FCFRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidades: FMRP; FFCLRP; FCFRP
- Subjects: CANNABIS; ANSIOLÍTICOS; EXTRATOS (FORMAS FARMACÊUTICAS)
- Language: Inglês
- Imprenta:
- Source:
- Título: European Neuropsychopharmacology
- Volume/Número/Paginação/Ano: v. 20, supl. 3, p. S542, res. P.4.c.002, 2010
- Conference titles: Congress of the European College of Neuropsychopharmacology (ECNP)
-
ABNT
BERGAMASCHI, M. M. et al. Anxiolytic effect of cannabidiol in subjects with social anxiety disorder. European Neuropsychopharmacology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 17 fev. 2026. , 2010 -
APA
Bergamaschi, M. M., Chagas, M. H. N., Chaves, D. I., Martinis, B. S. de, Grando, M. D., Freitas, M. C., et al. (2010). Anxiolytic effect of cannabidiol in subjects with social anxiety disorder. European Neuropsychopharmacology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Bergamaschi MM, Chagas MHN, Chaves DI, Martinis BS de, Grando MD, Freitas MC, Queiroz RHC, Hallak JEC, Zuardi AW, Crippa JA de S. Anxiolytic effect of cannabidiol in subjects with social anxiety disorder. European Neuropsychopharmacology. 2010 ; 20 S542.[citado 2026 fev. 17 ] -
Vancouver
Bergamaschi MM, Chagas MHN, Chaves DI, Martinis BS de, Grando MD, Freitas MC, Queiroz RHC, Hallak JEC, Zuardi AW, Crippa JA de S. Anxiolytic effect of cannabidiol in subjects with social anxiety disorder. European Neuropsychopharmacology. 2010 ; 20 S542.[citado 2026 fev. 17 ] - Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients
- Development and validation of a liquid-liquid extraction and gas chromatography/mass spectrometry methodology for cannabidiol analysis in human plasma
- Cannabidiol (CBD) for the treatment of bipolar affective disorder
- Development and validation of a liquid-liquid extraction and gas chromatography/mass spectrometry methodology for cannabidiol and delta 9-tetrahydrocannabinol in human plasma
- Safety and side effects of cannabidiol, a Cannabis sativa constituent
- Olanzapine, weight change and metabolic effects: a naturalistic 12-month follow up
- Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
